Drug target · TMEM97
σ2 receptor (TMEM97)
Sigma-2 receptor / transmembrane protein 97
2 compounds in the CNS pipeline act on σ2 receptor (TMEM97).
Compounds targeting σ2 receptor (TMEM97)
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| ZervimesineprimarySmall molecule | Antagonist | — | Phase 2Alzheimer's disease | Cognition Therapeutics, Inc. |
| Roluperidone (MIN-101)Small molecule | Antagonist | Ki 7.53 nM | Phase 3Schizophrenia | Minerva Neurosciences, Inc. |